Complications, functional outcome and quality of life after intensive preoperative chemoradiotherapy for rectal cancer

European Journal of Surgical Oncology

Volumn 32, Issue 10, 2006, Pages 1201-1208

  Urso, E ^a   Serpentini, S ^a   Pucciarelli, S ^a   De Salvo, G L ^b   Friso, M L ^c   Fabris, G ^c   Lonardi, S ^c   Ferraro, B ^d   Bruttocao, A ^a   Aschele, C ^e   Nitti, D ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^d S ANTONIO HOSPITAL   (Italy)

^e GALLIERA HOSPITAL   (Italy)

Author keywords

Anorectal function; Chemoradiotherapy; Late complications; Quality of life; Rectal cancer; Surgery

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ACUTE TOXICITY; ADULT; AGE DISTRIBUTION; AGED; ANALYSIS OF VARIANCE; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FECES INCONTINENCE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; HUMAN TISSUE; INTENSIVE CARE; MALE; MULTICENTER STUDY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RECTUM ANTERIOR RESECTION; RECTUM CANCER; REOPERATION; SCORING SYSTEM; SEX DIFFERENCE; SURGICAL MORTALITY; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FECAL INCONTINENCE; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; ORGANOPLATINUM COMPOUNDS; POSTOPERATIVE COMPLICATIONS; QUALITY OF LIFE; QUESTIONNAIRES; RECTAL NEOPLASMS; RECTUM;

EID: 33751268959     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.07.003     Document Type: Article

References (44)

1. Sauer R., Becker H., Hohenberger W., et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351 (2004) 1731-1740
2. Janian N.A., Khoo V.S., Abbruzzese J., et al. Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M.D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 44 (1999) 1027-1038
3. Janjan N.A., Crane C., Feig B.W., et al. Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol 24 (2001) 107-112
4. Moore H.G., Riedel E., Minsky B.D., et al. Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy. Ann Surg Oncol 10 (2003) 80-85
5. Grann A., Feng C., Wong D., et al. Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma. Int J Radiat Oncol Biol Phys 49 (2001) 987-995
6. Habr-Gama A., de Souza P.M., Ribeiro Jr. U., et al. Low rectal cancer: impact of radiation and chemotherapy on surgical treatment. Dis Colon Rectum 41 (1998) 1087-1096
7. Minsky B., Cohen A., Enker W., et al. Preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for rectal cancer. Cancer 73 (1994) 273-280
8. Rich T.A., Skibber J.M., Ajani J.A., et al. Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys 32 (1995) 1025-1029
9. Luna-Perez P., Rodriguez-Ramirez S., Hernandez-Pacheco F., Gutierrez De La Barrera M., Fernandez R., and Labastida S. Anal sphincter preservation in locally advanced low rectal adenocarcinoma after preoperative chemoradiation therapy and coloanal anastomosis. J Surg Oncol 82 (2003) 3-9
10. Pucciarelli S., Toppan P., Friso M.L., et al. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome. Dis Colon Rectum 47 (2004) 1798-1807
11. Theodoropulos G., Padmanabhan A., Kerner B.A., Taylor C.W., Aguila P.S., and Khaduja K.S. T-level downstaging and complete pathological response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum 45 (2002) 895-899
12. Mohiuddin M., Hayne M., Regine W.F., et al. Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent cancers. Int J Radiat Oncol Biol Phys 48 (2000) 1075-1080
13. Aschele C., Friso M.L., Pucciarelli S., et al. A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer. Ann Oncol 16 (2005) 1140-1146
14. Gerard J.P., Chapet O., Nemoz C., et al. Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial. J Clin Oncol 21 (2003) 1119-1124
15. Carraro S., Roca E.L., Cartelli C., et al. Radiochemotherapy with short daily infusion of low-dose oxaliplatin, leucovorin, and 5-FU in T3-T4 unresectable rectal cancer: a phase II IATTGI study. Int J Radiat Oncol Biol Phys 54 (2002) 397-402
16. Gambacorta M.A., Valentini V., Morganti A.G., et al. Chemoradiation with raltitrexed (Tomudex) in preoperative treatment of stage II-III resectable rectal cancer: a phase II study. Int J Radiat Oncol Biol Phys 60 (2004) 130-138
17. Klautke G., Feyerherd P., Ludwig K., Prall F., Foitzik T., and Fietkau R. Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancer. Br J Cancer 92 (2005) 1215-1220
18. Chiesura-Corona M., Muzzio P.C., Giust G., Zuliani M., Pucciarelli S., and Toppan P. Rectal cancer: CT local staging with histopathologic correlation. Abdom Imaging 26 (2001) 134-138
19. Arbuck S.G., Ivy S.P., Setser A., et al. The revised common toxicity criteria. version 2. CTEP website. http://ctep.info.nih.gov
20. Enker W.E., Thaler H.T., Cranor M.L., and Polyak T. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 181 (1995) 335-346
21. Quirke P., Durdey P., Dixon M.F., and Williams N.S. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumor spread and surgical excision. Lancet 2 (1986) 996-999
22. Fleming D.I., Cooper S.J., Henson E.D., et al. AJCC cancer staging manual. 5th edition (1997), Lippincott-Raven, Philadelphia, PA p. 83-90
23. Mandard A.M., Dalibard F., Mandard J.C., et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 73 (1994) 2680-2686
24. Compton C.C., Fielding L.P., Burgart L.J., et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124 (2000) 979-994
25. Wong W.D., Congliosi S.M., Spencer M.P., et al. The safety and efficacy of the artificial bowel sphincter for fecal incontinence: result from a multicenter cohort study. Dis Colon Rectum 45 (2002) 1139-1153
26. Sprangers M.A.G., te Velde A., and Aaronson N.K. The construction and testing of the EORTC Colorectal Cancer Specific Quality of Life questionnaire Module (the QLQ-CR 38). Eur J Cancer 35 (1999) 238-247
27. Enker W.E., Merchant N., Cohen A.M., et al. Safety and efficacy of low anterior resection for rectal cancer: 681 consecutive cases from a specialty service. Ann Surg 230 (1999) 544-552
28. Zaheer S., Pemberton J.H., Farouk R., Dozois R.R., Wolff B.G., and Ilstrup D. Surgical treatment of adenocarcinoma of the rectum. Ann Surg 227 (1998) 800-811
29. Marijnen C.A., Kapiteijn E., van de Velde C.J., et al. Cooperative Investigators of the Dutch Colorectal Cancer Group. Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 20 (2002) 817-825
30. Karanjia N.D., Corder A.P., Bearn P., and Heald R.J. Leakage from stapled low anastomosis after total mesorectal excision for carcinoma of the rectum. Br J Surg 81 (1994) 1224-1226
31. Vignali A., Fazio V.W., Lavery I.C., et al. Factors associated with the occurrence of leaks in stapled rectal anastomoses: a review of 1,014 patients. Am Coll Surg 185 (1997) 105-113
32. Rodel C., Grabenbauer G.G., Papadopoulos T., Hohenberger W., Schmoll H.J., and Sauer R. Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. J Clin Oncol 21 (2003) 3098-3104
33. Valentini V., Coco C., Cellini N., et al. Preoperative chemoradiation with cisplatin and 5-fluorouracil for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, sphincter preservation. Int J Radiat Oncol Biol Phys 45 (1999) 1175-1184
34. Chari R.S., Tyler D.S., Anscher M.S., et al. Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann Surg 221 (1995) 778-786
35. Vaizey C.J., Carapeti E., Cahill J.A., and Kamm M.A. Prospective comparison of faecal incontinence grading systems. Gut 44 (1999) 77-80
36. van Duijvendijk P., Slors J.F.M., Taat C.W., et al. Prospective evaluation of anorectal function after total mesorectal excision for rectal carcinoma with or without preoperative radiotherapy. Am J Gastroenterol 97 (2002) 2282-2289
37. Nathanson D.R., Espat N.J., Garret M., et al. Evaluation of preoperative and postoperative radiotherapy on long term functional results of straight coloanal anastomosis. Dis Colon Rectum 46 (2003) 888-894
38. Grumann M.M., Noack E.M., Hoffmann I.A., and Schlag P.M. Comparison of quality of life in patients undergoing abdominoperineal extirpation or anterior resection for rectal cancer. Ann Surg 233 (2001) 149-156
39. Camilleri-Brennan J., and Steele R.J. Prospective analysis of quality of life and survival following mesorectal excision for rectal cancer. Br J Surg 88 (2001) 1617-1622
40. Guren M.G., Dueland S., Skovlund E., Fossa S.D., Poulsen J.P., and Tveit K.M. Quality of life during radiotherapy for rectal cancer. Eur J Cancer 39 (2003) 587-594
41. Engel J., Kerr J., Schlesinger-Raab A., Eckel R., Sauer H., and Holzel D. Quality of life in rectal cancer patients: a four-year prospective study. Ann Surg 238 (2003) 203-213
42. Sailer M., Fuchs K.H., Fein M., and Thiede A. Randomized clinical trial comparing quality of life after straight and pouch coloanal reconstruction. Br J Surg 89 (2002) 1108-1117
43. Allal A.S., Bieri S., Pelloni A., et al. Sphincter-sparing surgery after preoperative radiotherapy for low rectal cancers: feasibility, oncologic results and quality of life outcomes. Br J Cancer 82 (2000) 1131-1137
44. Rauch P., Miny J., Conroy T., Neyton L., and Guillemin F. Quality of life among disease-free survivors of rectal cancer. J Clin Oncol 22 (2004) 354-360